The Insulin Delivery Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of insulin delivery devices has experienced significant growth recently. It is predicted to increase from $17.71 billion in 2024 to $19.22 billion in 2025, projecting a compound annual growth rate (CAGR) of 8.5%.
The Insulin Delivery Devices market is anticipated to reach a value of $26.3 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.2%.
Download Your Free Sample of the 2025 Insulin Delivery Devices Market Report and Uncover Key Trends Now!The drivers in the insulin delivery devices market are:
• Rising convenience and ease of use of insulin delivery devices
• Implementation of favorable reimbursement policies
• Growing prevalence of obesity bolstering demand for insulin
• Rising aging population leading to increased need for insulin pumps
The insulin delivery devices market covered in this report is segmented –
1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps
2) By Disease Indication: Type 1, Type 2
3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers
The trends in the insulin delivery devices market are:
• Technological advancements in insulin delivery devices are emerging as a key trend.
• The integration of digital technology with insulin delivery devices is becoming increasingly popular.
• The development of artificial pancreas systems is a significant emerging trend.
• Advancements in insulin administration technology and bionic technology are shaping the future of this market.
The major players in the insulin delivery devices market are:
• Sanofi SA
• Abbott Laboratories
North America was the largest region in the insulin delivery devices market in 2023